在人类瘤中对TIPRL进行泛癌生物信息学分析
Xuezhong Zhang1, Hao Xue2, Yuanyuan Lv3
1Department of Laboratory Medicine, Zibo Central Hospital, Zibo, Shandong, China.
Discover oncology
|March 15, 2025
概括
在大多数癌症中,TOR信号通路调节器类 (TIPRL) 基因升高,与较差的存活率有关,这表明它是癌症进展和免疫调节的关键生物标志物. 建议进一步研究TIPRL的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 类似TOR信号通路调节器 (TIPRL) 基因在癌症中起着复杂的作用,但其全面的泛癌特征尚不清楚.
- 研究TIPRL在各种癌症中的表达和功能对于确定潜在的治疗点至关重要.
研究的目的:
- 为了全面分析TIPRL的泛癌表达特征.
- 调查TIPRL与患者存活率,遗传改变,免疫透和关键癌症相关途径的关联.
主要方法:
- 使用TCGA_GTEx和CPTAC数据库进行表达和生存分析.
- 雇佣了GEPIA2,UALCAN和cBioPortal用于表达,改变和结构分析.
- 评估了RNA修饰,免疫细胞透,瘤突变负担 (TMB),微卫星不稳定性 (MSI),同源重组缺陷 (HRD) 以及使用R,STRING和生存分析进行途径丰富.
主要成果:
- 在大多数癌症中,TIPRL表达上调,与几种类型 (例如,ACC,BRCA,HNSC) 的生存率较差相关.
- 放大是TIPRL的主要遗传改变,具有不同的临床意义.
- TIPRL与免疫细胞透具有复杂的相关性,并与基因组不稳定性标记物 (TMB,MSI,HRD) 有关.
- 丰富分析表明TIPRL参与了氧化酸化和自,这对瘤发生至关重要.
结论:
- TIPRL作为一个重要的泛癌生物标志物用于预后和免疫调节.
- 这些发现凸显了TIPRL作为各种癌症类型的潜在治疗标.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.5K
11:20Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
10.8K
相关概念视频
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
